Protect Pharmaceutical Corporation
PRTT
$1.24
-$0.06-4.62%
| 06/30/2018 | 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -99.51% | 87.27% | 176.74% | 358.70% | 356.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -99.51% | 87.27% | 176.74% | 358.70% | 356.55% |
| Operating Income | 99.51% | -87.27% | -176.74% | -358.70% | -356.55% |
| Income Before Tax | 89.53% | -107.68% | -194.00% | -369.97% | 77.51% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 89.53% | -107.68% | -194.00% | -369.97% | 77.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 89.53% | -107.68% | -194.00% | -369.97% | 77.51% |
| EBIT | 99.51% | -87.27% | -176.74% | -358.70% | -356.55% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 89.46% | -107.69% | -194.40% | -371.48% | 77.48% |
| Normalized Basic EPS | 89.45% | -107.31% | -193.62% | -369.70% | -357.95% |
| EPS Diluted | 89.87% | -87.43% | -158.55% | -343.71% | 76.57% |
| Normalized Diluted EPS | 90.20% | -105.32% | -192.77% | -368.48% | -357.95% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 8.33% | 8.33% | 2.78% | 2.78% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
